Name | 1-[5-(4-amino-7-methylpyrrolo[2,3-d]pyrimidin-5-yl)-2,3-dihydroindol-1-yl]-2-[3-fluoro-5-(trifluoromethyl)phenyl]ethanone |
---|---|
Synonyms |
Ethanone, 1-[5-(4-amino-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-2,3-dihydro-1H-indol-1-yl]-2-[3-fluoro-5-(trifluoromethyl)phenyl]-
1-[5-(4-Amino-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-2,3-dihydro-1H-indol-1-yl]-2-[3-fluoro-5-(trifluoromethyl)phenyl]ethanone GSK PERK Inhibitor |
Description | PERK-IN-4 is a potent and selective PERK (protein kinase R (PKR)-like endoplasmic reticulum kinase) inhibitor with an IC 50 of 0.3 nM. PERK is activated in response to a variety of endoplasmic reticulum stresses implicated in numerous disease states[1]. |
---|---|
Related Catalog | |
Target |
IC50: 0.3 nM (PERK)[1] |
References |
Density | 1.5±0.1 g/cm3 |
---|---|
Boiling Point | 710.9±60.0 °C at 760 mmHg |
Molecular Formula | C24H19F4N5O |
Molecular Weight | 469.434 |
Flash Point | 383.7±32.9 °C |
Exact Mass | 469.152588 |
PSA | 77.04000 |
LogP | 4.42 |
Vapour Pressure | 0.0±2.3 mmHg at 25°C |
Index of Refraction | 1.660 |